Cancer Family
Malignant Breast Neoplasm
CI-CAN-00000227Explore in graph →
Top-level2,627 active trials43 approved drugs310 evidence items
- NCIt
- C9335
- ICD-10
- C50
- DOID
- 1612
- Other
- 2 more codes
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000227Explore in graph →
Clinical trials
12,360 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,368)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00014222 | Combination Chemotherapy With or Without Colony-stimulating Factors in Treating Women With Breast Cancer | completed | Phase 3 | 2,104 | NCIC Clinical Trials GroupNETWORK | 2 | Oct 5, 2020 | clinicaltrials |
| NCT01810393 | A Study to Assess Preference for Subcutaneous Trastuzumab Treatment in Participants With Human Epidermal Growth Factor Receptor (HER)2-Positive Metastatic Breast Cancer Responding to First-Line Intravenous Trastuzumab for at Least 3 Years | completed | Phase 3 | 114 | Hoffmann-La RocheINDUSTRY | 1 | Sep 4, 2020 |
| clinicaltrials |
| NCT01610284 | Phase III Study of BKM120/Placebo With Fulvestrant in Postmenopausal Patients With Hormone Receptor Positive HER2-negative Locally Advanced or Metastatic Breast Cancer Refractory to Aromatase Inhibitor(BELLE-2) | completed | Phase 3 | 1,147 | Novartis PharmaceuticalsINDUSTRY | 29 | Aug 25, 2020 | clinicaltrials |
| NCT00005970 | Doxorubicin Hydrochloride, Cyclophosphamide, and Pacltaxel With or Without Trastuzumab in Treating Women With HER2-Positive Node-Positive or High-Risk Node-Negative Breast Cancer | completed | Phase 3 | 3,436 | National Cancer Institute (NCI)NIH | 4 | Aug 14, 2020 | clinicaltrials |
| NCT01000662 | Study Comparing Whole Breast Radiotherapy With a Daily Versus a Weekly Tumor | completed | Phase 3 | 412 | NYU Langone HealthOTHER | 1 | Aug 6, 2020 | clinicaltrials |
| NCT01583426 | Nanoparticle-based Paclitaxel vs Solvent-based Paclitaxel as Part of Neoadjuvant Chemotherapy for Early Breast Cancer (GeparSepto)(GeparSepto) | completed | Phase 3 | 1,229 | GBG Forschungs GmbHOTHER | 1 | Aug 6, 2020 | clinicaltrials |
| NCT00047255 | Docetaxel and Trastuzumab With or Without Carboplatin in Treating Women With HER2-Positive Breast Cancer | completed | Phase 3 | 263 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Aug 3, 2020 | clinicaltrials |
| NCT01950182 | Trastuzumab Combined With Chemotherapy or Endocrine Therapy to Treat Metastatic Luminal B2 Breast Cancer(SYSUCC-002) | completed | Phase 3 | 392 | Sun Yat-sen UniversityOTHER | 1 | Jul 15, 2020 | clinicaltrials |
| NCT02429427 | European Celecoxib Trial in Primary Breast Cancer(REACT) | completed | Phase 3 | 2,639 | Imperial College LondonOTHER | 0 | Jun 23, 2020 | clinicaltrials |
| NCT00337103 | E7389 Versus Capecitabine in Patients With Locally Advanced or Metastatic Breast Cancer Previously Treated With Anthracyclines and Taxanes | completed | Phase 3 | 1,276 | Eisai Inc.INDUSTRY | 23 | Jun 18, 2020 | clinicaltrials |
| NCT01112826 | Efficacy of Capecitabine Metronomic Chemotherapy to Triple-negative Breast Cancer(SYSUCC-001) | completed | Phase 3 | 443 | Sun Yat-sen UniversityOTHER | 1 | May 27, 2020 | clinicaltrials |
| NCT01216111 | Adjuvant Platinum and Taxane in Triple-negative Breast Cancer (PATTERN) | completed | Phase 3 | 647 | Fudan UniversityOTHER | 0 | May 19, 2020 | clinicaltrials |
| NCT00003088 | Combination Chemotherapy in Treating Patients With Breast Cancer | completed | Phase 3 | 2,005 | Alliance for Clinical Trials in OncologyOTHER | 2 | Apr 29, 2020 | clinicaltrials |
| NCT00003855 | Lymph Node Removal in Treating Women Who Have Stage I or Stage IIA Breast Cancer | completed | Phase 3 | 605 | Alliance for Clinical Trials in OncologyOTHER | 4 | Apr 29, 2020 | clinicaltrials |
| NCT04031703 | Study Comparing Paclitaxel Plus Carboplatin Versus Anthracyclines Followed by Docetaxel as Adjuvant Chemotherapy for Triple Negative Breast Cancer (PATTERN) | completed | Phase 3 | 647 | Fudan UniversityOTHER | 0 | Apr 24, 2020 | clinicaltrials |
| NCT00354302 | Bone Mineral Density in Postmenopausal Women With Primary Breast Cancer Who Are Receiving Treatment on Clinical Trial | completed | Phase 3 | 497 | NCIC Clinical Trials GroupNETWORK | 1 | Apr 2, 2020 | clinicaltrials |
| NCT00002542 | Tamoxifen in Treating Women With High-Risk Breast Cancer | completed | Phase 3 | 672 | NCIC Clinical Trials GroupNETWORK | 1 | Apr 1, 2020 | clinicaltrials |
| NCT00002864 | Tamoxifen With or Without Octreotide in Treating Postmenopausal Women With Stage I, Stage II, or Stage III Breast Cancer | completed | Phase 3 | 667 | NCIC Clinical Trials GroupNETWORK | 2 | Apr 1, 2020 | clinicaltrials |
| NCT00003032 | High Dose Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Standard Therapy in Treating Women With Metastatic or Recurrent Breast Cancer | completed | Phase 3 | 224 | NCIC Clinical Trials GroupNETWORK | 1 | Apr 1, 2020 | clinicaltrials |
| NCT02861859 | Individualised Versus Standard Care for Breast Cancer Patients at High-risk for Chemotherapy-induced Nausea and Vomiting The ILIAD Study | completed | Phase 3 | 221 | Ottawa Hospital Research InstituteOTHER | 1 | Feb 26, 2020 | clinicaltrials |
| NCT01099436 | Neo-Adjuvant Chemotherapy (TAC) With or Without Zoledronic Acid in Treating HER2-negative Breast Cancer Patients(NEO-ZOTAC) | completed | Phase 3 | 250 | Borstkanker Onderzoek GroepNETWORK | 1 | Jan 21, 2020 | clinicaltrials |
| NCT01935492 | 8 Continuous vs 8 Intermittent Cycles in First and Second Line in HER2/Neu Neg Metastatic Breast Cancer(Stop&Go) | completed | Phase 3 | 420 | Borstkanker Onderzoek GroepNETWORK | 1 | Jan 18, 2020 | clinicaltrials |
| NCT02961790 | Oxybutynin Chloride in Managing Hot Flashes | completed | Phase 3 | 150 | Academic and Community Cancer Research UnitedOTHER | 1 | Jan 18, 2020 | clinicaltrials |
| NCT00388726 | E7389 Versus Treatment of Physician's Choice in Patients With Locally Recurrent or Metastatic Breast Cancer | completed | Phase 3 | 762 | Eisai Inc.INDUSTRY | 17 | Jan 7, 2020 | clinicaltrials |
| NCT00068601 | S0230 Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer | completed | Phase 3 | 257 | SWOG Cancer Research NetworkNETWORK | 6 | Dec 30, 2019 | clinicaltrials |
| NCT00600340 | 2-arm Trial of Paclitaxel Plus Bevacizumab vs. Capecitabine Plus Bevacizumab(TURANDOT) | completed | Phase 3 | 564 | Central European Cooperative Oncology GroupOTHER | 12 | Dec 30, 2019 | clinicaltrials |
| NCT00390455 | Fulvestrant With or Without Lapatinib in Treating Postmenopausal Women With Stage III or Stage IV Breast Cancer That is Hormone Receptor-Positive | completed | Phase 3 | 295 | National Cancer Institute (NCI)NIH | 1 | Dec 20, 2019 | clinicaltrials |
| NCT00567190 | A Study to Evaluate Pertuzumab + Trastuzumab + Docetaxel vs. Placebo + Trastuzumab + Docetaxel in Previously Untreated HER2-Positive Metastatic Breast Cancer(CLEOPATRA) | completed | Phase 3 | 808 | Genentech, Inc.INDUSTRY | 26 | Dec 13, 2019 | clinicaltrials |
| NCT00001806 | Methods in Education for Breast Cancer Genetics | completed | Phase 3 | 170 | National Cancer Institute (NCI)NIH | 1 | Dec 12, 2019 | clinicaltrials |
| NCT00536081 | Various G-CSF Regimens to Prevent Infection During Chemotherapy | completed | Phase 3 | 172 | Academisch Ziekenhuis MaastrichtOTHER | 1 | Nov 6, 2019 | clinicaltrials |
| NCT00393172 | Women in Steady Exercise Research [Formerly Women, Oxidative Stress, Exercise and Estrogens (WOSEE)](WISER) | completed | Phase 2 / Phase 3 | 400 | University of MinnesotaOTHER | 1 | Nov 1, 2019 | clinicaltrials |
| NCT02126449 | DIetary REstriction as an Adjunct to Neoadjuvant ChemoTherapy for HER2 Negative Breast Cancer(DIRECT) | completed | Phase 2 / Phase 3 | 131 | Leiden University Medical CenterOTHER | 1 | Oct 24, 2019 | clinicaltrials |
| NCT01104935 | National Surgical Adjuvant Study of Breast Cancer(N-SAS BC) 07 [RESPECT](RESPECT) | completed | Phase 3 | 275 | Comprehensive Support Project for Oncology ResearchOTHER | 1 | Oct 21, 2019 | clinicaltrials |
| NCT02376985 | Evaluation of Oral Care to Prevent Oral Mucositis in ER Positive MBC Patients Treated With Everolimus: Phase 3 RCT | completed | Phase 3 | 174 | Comprehensive Support Project for Oncology ResearchOTHER | 1 | Oct 21, 2019 | clinicaltrials |
| NCT01591746 | Botulinum Toxin A (Botox) in Tissue Expander Breast Reconstruction | completed | Phase 3 | 131 | Mayo ClinicOTHER | 1 | Oct 10, 2019 | clinicaltrials |
| NCT01856543 | Mometasone Furoate 0.1% Versus Eucerin on Moderate to Severe Skin Toxicities in Breast Cancer Patients Receiving Postmastectomy Radiation | completed | Phase 3 | 143 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Oct 3, 2019 | clinicaltrials |
| NCT02115204 | 4 x Epirubicin, Cyclophosphamide, Followed by 4 x Docetaxel Versus 6 x CMF / 6 x CEF | completed | Phase 3 | 2,011 | Women's Cancer Study Group GmbHOTHER | 1 | Oct 3, 2019 | clinicaltrials |
| NCT00295620 | Secondary Adjuvant Long Term Study With Arimidex(SALSA) | completed | Phase 3 | 3,484 | AstraZenecaINDUSTRY | 1 | Oct 2, 2019 | clinicaltrials |
| NCT01926886 | A Study of Subcutaneous At Home Administration of Trastuzumab (Herceptin) in Participants With Human Epidermal Growth Factor Receptor 2-positive (HER2+) Early Breast Cancer (eBC) | completed | Phase 3 | 102 | Hoffmann-La RocheINDUSTRY | 2 | Sep 18, 2019 | clinicaltrials |
| NCT01091168 | Trial of Vinflunine Versus Alkylating Agent in Metastatic Breast Cancer | completed | Phase 3 | 594 | Pierre Fabre MedicamentINDUSTRY | 14 | Sep 16, 2019 | clinicaltrials |
| NCT02402712 | Phase IIIb Study to Evaluate the Safety and Tolerability of Herceptin SC With Perjeta and Docetaxel in Patients With HER2-positive Advanced Breast Cancer | completed | Phase 3 | 418 | Hoffmann-La RocheINDUSTRY | 12 | Sep 6, 2019 | clinicaltrials |
| NCT02040935 | A Study of SC Administration of Trastuzumab (Herceptin) by SID at Home in HER2-Positive EBC Participants(HOMERUS) | completed | Phase 3 | 128 | Hoffmann-La RocheINDUSTRY | 1 | Aug 22, 2019 | clinicaltrials |
| NCT01901146 | Efficacy and Safety Study of ABP 980 Compared With Trastuzumab in Women With HER2-positive Early Breast Cancer(Lilac) | completed | Phase 3 | 725 | AmgenINDUSTRY | 18 | Aug 7, 2019 | clinicaltrials |
| NCT02408393 | MIRs03: Paravertebral Block With Ropivacaine Before Breast Cancer Surgery(MIRs03) | completed | Phase 3 | 380 | Institut CurieOTHER | 1 | Jul 10, 2019 | clinicaltrials |
| NCT02995772 | Neoadjuvant Hormonal Therapy Compared to Neoadjuvant Chemotherapy in Stage IIIB/C and IV Breast Cancer Patients | completed | Phase 3 | 122 | Dharmais National Cancer Center HospitalOTHER_GOV | 1 | Jun 19, 2019 | clinicaltrials |
| NCT01645839 | Interest of Intrathecal Chemotherapy With Liposomal Cytarabine (DepoCyte®) in Meningeal Metastasis of Breast Cancer(DEPOSEIN) | completed | Phase 3 | 74 | Centre Oscar LambretOTHER | 1 | Jun 12, 2019 | clinicaltrials |
| NCT00144898 | GF-GS 01: Comparing Conventional Axillary Dissection Versus Sentinel Node Resection in Clinically Node-negative Operable Breast Cancer | completed | Phase 3 | 1,627 | Hospices Civils de LyonOTHER | 1 | May 28, 2019 | clinicaltrials |
| NCT00992706 | F511 Cream in Preventing Palmar-Plantar Erythrodysesthesia in Patients Receiving Doxorubicin Hydrochloride Liposome for Metastatic Breast Cancer | completed | Phase 3 | 91 | Swiss Cancer InstituteOTHER | 1 | May 15, 2019 | clinicaltrials |
| NCT01131195 | Metronomic Therapy in Metastatic Breast Cancer. | completed | Phase 3 | 139 | Swiss Cancer InstituteOTHER | 1 | May 15, 2019 | clinicaltrials |
Data updated 23 days agoSource updated Oct 5, 2020source: clinicaltrials